Author:

The social value of decreasing health risks to people of different age, health status, and income depends on the evaluation framework employed in an analysis. These values can be evaluated using cost-effectiveness

Fangli Geng, Ph.D. candidate at CHDS, collaborated with researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College to develop

COVID-19 vaccination is substantially more cost-effective than lockdowns, according to research conducted by CHDS faculty affiliate Joseph Pliskin and Ronen Arbel. Early in the COVID-19

Jinyi Zhu, 6th year doctoral student in Decision Science/Health Policy, successfully defended her thesis, “Decision Modeling to Inform Resource Prioritization: Methods and

FAMNET research assistant Cassidy Bargell faced quality of life decision making in real-time last fall when confronted with a serious illness. As described recently in a Harvard Gazette feature article, Cass experienced

Maurice Smith discussed the human brain’s control of motor behavior and learning in a recent CHDS seminar. Smith is Professor of Bioengineering at the Harvard Paulson School of Engineering and

Sherry Glied, Dean of the Wagner School of Public Service and former Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, discussed the path from

CHDS faculty Nicole Gastineau Campos and National Cancer Institute Senior Investigators Anil K. Chaturvedi and Aimée R. Kreimer proposed guidance for HPV vaccine effectiveness studies

The Family Well-Being Research Network (FAMNET) announces pilot grants for research on the measurement of family well-being. A collaborative effort among HSPH, the University of Michigan, and the University

CHDS faculty Nicolas Menzies has been promoted to associate professor of global health at the Harvard T.H. Chan School of Public Health. Menzies’s research uses quantitative techniques, including